中新网北京10月27日电 (记者 欧阳开宇)中国九家大医院27日在北京共同启动了一项关于卵巢癌诊断的新型肿瘤标志物——人附睾蛋白4(HE4)的临床研究项目。

Beijing on October 27 - Beijing (Reporter OuYangKaiYu)China's nine big hospital 27 in Beijing jointly launched a ovarian cancer diagnosis about new type of tumor markers -- people epididymis protein 4(HE4)Clinical research project.

　　卵巢癌是女性生殖器官常见的肿瘤之一，属于妇科肿瘤死亡率较高的肿瘤类型，由于卵巢癌的临床症状不明显，容易造成漏诊和误诊。

Ovarian cancer is female reproductive organs is one of the most common cancer,Belong to gynecology tumor mortality higher tumor type,Due to the clinical symptoms of ovarian cancer is not obvious,Easy to cause the missed diagnosis and misdiagnosis.

　　复旦大学医学院附属肿瘤医院郭林教授指出，尽管卵巢癌的预后较差，但如果癌细胞能在仅存于卵巢内时就被尽早诊断出来，患者便很有可能被治愈。因此，在卵巢癌管理中，早期诊断和治疗监测尤为重要。

Fudan university school of medicine attached tumour hospital GuoLin professor noted that,Although the prognosis of ovarian cancer is poor,But if the cancer cells can only exist in ovarian inside when they were diagnosed as early as possible,Patients will very likely be cured.therefore,In the management of ovarian cancer,Early diagnosis and treatment is particularly important monitoring.

　　专家介绍说，目前，卵巢癌的诊断主要依据两种检测手段，一种是经阴道超声检查，这种成像方法可用于检查女性的生殖器官，尽管应用较普遍，但是却不能准确检测出该肿块是良性还是恶性。另一种常规检测方法是检测生物标志物CA125，这种方法的缺点是特异性较低。

Experts say,At present,The diagnosis of ovarian cancer mainly based on two kinds of detection means,One kind is vaginal ultrasound examination,This kind of imaging method can be used to check the female reproductive organs,Although used more common,But can not accurately detect the tumor is benign or malignant.Another kind of conventional detection method is to test the biological marker CA125,The disadvantage of this method is low specific.

　　解放军总医院田亚平教授表示，中国开展HE4水平参考值的研究，将使HE4在中国的临床应用更加具有指导性和针对性。

The people's liberation army general hospital TianYaPing professor said,China carry out HE4 level reference study,Will make the clinical application of HE4 in China more has the guidance and pertinence.

　　当天启动的项目研究样本量超过2000例、覆盖了20-79岁的女性，旨在通过更好的评估HE4在不同疾病人群的水平分布，确定中国人群HE4参考值范围，帮助更多中国患者实现卵巢癌的早期诊断，预计在2013年3月完成。

The start of the project research sample size more than 2000 cases/Cover the 20-79 - year - old woman,Aims to better evaluate HE4 in different horizontal distribution of the disease,Sure Chinese people HE4 reference range,Help more Chinese patients realize the early diagnosis of ovarian cancer,Is expected to complete in March 2013.

　　这九家大型三甲医院及肿瘤专科医院分别是解放军总医院、天津市肿瘤医院、复旦大学附属肿瘤医院、山东大学齐鲁医院、福建医科大学第一附属医院、厦门大学附属中山医院、华中科技大学同济医学院附属同济医院、中山大学附属肿瘤医院及新疆医科大学附属肿瘤医院。(完)

These nine large-scale 3 armour hospital and tumor hospitals were the people's liberation army general hospital/Tianjin tumour hospital/Fudan university attached tumour hospital/Shandong university qilu hospital/The first affiliated hospital of fujian medical university/Xiamen university affiliated hospital of sun yat-sen/Central China university of science and technology tongji medical college affiliated tongji hospital/Sun yat-sen university attached tumour hospital and xinjiang medical university attached tumour hospital.(finish)